K-TRACS USER GUIDE

No. K.S.A. 65-1687 prohibits the storage of K-TRACS data outside the online database. Providers are encouraged to seek EMR integration or use a delegate to help facilitate review of the patient report in lieu of printing. Providers are encouraged to document review of the report — and any conversation that was had with the patient regarding the report — in the patient's chart, but the report cannot be stored in individual medical records.

No. K.S.A. 65-1687 prohibits the storage of K-TRACS data outside the online database. Providers are encouraged to document review of the report — and any conversation that was had with the patient regarding the report — in the patient's chart, but the report cannot be stored in individual medical records.

Yes. Providers are encouraged to discuss K-TRACS reports with patients to educate them about how they use K-TRACS in their clinical decision-making. If the report highlights any concerns, these should be discussed with the patient.

Providers should not give a copy of the report to the patient — the patient can request a copy directly from K-TRACS.

No. K-TRACS should only be used for the medical and pharmaceutical care of a patient or a prospective patient. Providers may use K-TRACS to search for patients requesting admission to their practice and/or seeking to transfer medications to their pharmacy for the first time.

Never use K-TRACS to search for anyone not a patient under your care, including prospective employees, family members or yourself.

No. Providers should not use K-TRACS on its own to make any clinical decision. Providers should not use a K-TRACS patient report as the basis for denying a patient admission to their practice or to dismiss a patient from their practice. Other clinical tools should be consulted before making these decisions.

K-TRACS is one of many clinical tools you can use to inform your decision-making process. It should be consulted in tandem with many other tools to make the best clinical decision for the patient.

No. Providers should not use any single element on the K-TRACS patient report to deny access to care. Providers should take into consideration all clinical tools at their disposal to make the best clinical decision for the patient.

Risk scores displayed on the K-TRACS patient report are meant to alert providers of potentially risky use of controlled substances. The scores should not be used as the sole source of a clinical decision.

K.S.A. 65-1683 provides for the following cases in which a user's access may be removed:

• Kansas regulatory boards are required to notify K-TRACS of any denial, suspension, revocation or other administrative limitation of a licensee or registrant that would disqualify them from being authorized to use K-TRACS. Users may lose access based on these notifications.
• Supervising prescribers and pharmacists are required to notify K-TRACS of any action that would disqualify a delegate from being authorized to use K-TRACS. Supervisors may "reject" a delegate by using the Delegate Management feature in K-TRACS, or they may notify K-TRACS to have the delegate's access removed based on license revocation, termination or other change in employment.
• K-TRACS may, in its discretion, block any user's access to the database if it has reason to believe the user may have inappropriately accessed or used patient information in violation of state or federal law.